Anaplastic large cell lymphoma (ALCL), ALK-negative, is a subtype of non-Hodgkin lymphoma characterized by the proliferation of large, atypical lymphoid cells. This condition primarily affects lymph nodes and can present with systemic symptoms such as fever, weight loss, and night sweats. The ICD-10 code C84.78 facilitates accurate diagnosis, documentation, and billing, ensuring proper treatment and public health reporting.
ICD-10 Code C84.78 represents Anaplastic large cell lymphoma, ALK-negative, affecting multiple lymph nodes. This code is used when documenting cases of ALCL that do not express the anaplastic lymphoma kinase (ALK) protein, which is significant for treatment decisions and prognosis. It is essential for accurate clinical documentation and billing in healthcare settings.
Anaplastic large cell lymphoma, ALK-negative, is a malignant lymphoproliferative disorder that arises from T-cells and is characterized by the presence of large, atypical lymphoid cells. The condition can progress rapidly and requires prompt medical intervention. Early diagnosis is crucial for effective management and treatment.
ICD-10 Code C84.78 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with Anaplastic large cell lymphoma, ALK-negative. This code aids in capturing the complexity of the condition and supports appropriate billing in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.78 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-negative. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Anaplastic large cell lymphoma, ALK-negative, requires urgent medical attention and often necessitates hospitalization for treatment. Chemotherapy is the primary treatment modality.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.78 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count (CBC) with automated differential. |
| 77021 | CT scan of the chest, abdomen, and pelvis. |
Common Questions About Using ICD-10 Code C84.78 for Anaplastic large cell lymphoma, ALK-neg, nodes mult site
What are the common symptoms of Anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and skin lesions.
How is Anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of atypical lymphoid cells.
What is the treatment for Anaplastic large cell lymphoma?
Treatment usually involves chemotherapy, and in some cases, radiation therapy may be utilized. Supportive care is also important to manage symptoms and side effects.
Is Anaplastic large cell lymphoma curable?
The prognosis for Anaplastic large cell lymphoma varies based on factors such as stage at diagnosis and response to treatment. Some patients achieve remission, while others may have a more challenging course.
Clinical Notes
SOAP notes
DAP notes
AI medical notes